Package 0143-9583-01

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0143-9583-01
Digits Only 0143958301
Product NDC 0143-9583
Product ID 0143-9583_e36c07c2-a7ad-4d59-bdcc-fe16765b264b
Description

5 mL in 1 VIAL, GLASS (0143-9583-01)

Marketing

Marketing Status
Marketed Since 2010-12-20
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "e36c07c2-a7ad-4d59-bdcc-fe16765b264b", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726324"], "spl_set_id": ["9c6aa884-750e-4b11-9955-bc7ab6e9c2ad"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 VIAL, GLASS (0143-9583-01)", "package_ndc": "0143-9583-01", "marketing_start_date": "20101220"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "0143-9583_e36c07c2-a7ad-4d59-bdcc-fe16765b264b", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0143-9583", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA091032", "marketing_category": "ANDA", "marketing_start_date": "20101220", "listing_expiration_date": "20261231"}